Pinnacle Financial Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-730
| Closed | -$48.2K | – | 526 |
|
|
2024
Q4 | $48.2K | Hold |
730
| – | – | ﹤0.01% | 482 |
|
|
2024
Q3 | $48.2K | Sell |
730
-800
| -52% | -$52.8K | ﹤0.01% | 481 |
|
|
2024
Q2 | $146K | Sell |
1,530
-2,510
| -62% | -$240K | ﹤0.01% | 444 |
|
|
2024
Q1 | $386K | Buy |
4,040
+2,510
| +164% | +$240K | 0.01% | 346 |
|
|
2023
Q4 | $117K | Hold |
1,530
| – | – | ﹤0.01% | 425 |
|
|
2023
Q3 | $106K | Sell |
1,530
-2,563
| -63% | -$178K | ﹤0.01% | 405 |
|
|
2023
Q2 | $386K | Buy |
4,093
+2,563
| +168% | +$242K | 0.01% | 322 |
|
|
2023
Q1 | $127K | Hold |
1,530
| – | – | ﹤0.01% | 396 |
|
|
2022
Q4 | $114K | Hold |
1,530
| – | – | ﹤0.01% | 388 |
|
|
2022
Q3 | $126K | Buy |
+1,530
| New | +$126K | ﹤0.01% | 368 |
|
|
2022
Q2 | – | Sell |
-435
| Closed | -$51K | – | 439 |
|
|
2022
Q1 | $51K | Hold |
435
| – | – | ﹤0.01% | 384 |
|
|
2021
Q4 | $56K | Sell |
435
-220
| -34% | -$28.3K | ﹤0.01% | 411 |
|
|
2021
Q3 | $74K | Buy |
655
+220
| +51% | +$24.9K | ﹤0.01% | 390 |
|
|
2021
Q2 | $45K | Buy |
+435
| New | +$45K | ﹤0.01% | 397 |
|
|
2019
Q1 | – | Sell |
-4,137
| Closed | -$211K | – | 456 |
|
|
2018
Q4 | $211K | Sell |
4,137
-1,122
| -21% | -$57.2K | 0.02% | 305 |
|
|
2018
Q3 | $305K | Buy |
5,259
+3,759
| +251% | +$218K | 0.03% | 275 |
|
|
2018
Q2 | $73K | Buy |
+1,500
| New | +$73K | 0.01% | 328 |
|
|
2017
Q3 | – | Sell |
-1,050
| Closed | -$41K | – | 329 |
|
|
2017
Q2 | $41K | Buy |
+1,050
| New | +$41K | 0.01% | 355 |
|